Concepedia

Oliver Langer

OL

Statistics

Publications

120

Citations

4.8K

H-Index

40

Active since

1999

Affiliations

Medical University of Vienna(Current)

Austrian Institute of Technology

University of Vienna

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

University of Veterinary Medicine Hannover, Foundation

Oliver Langer is an author at Medical University of Vienna specializing in medicine, pharmacology, and blood-brain barrier pharmacology.

ORCID

Publications per year

1999–2024

120

Publications

120

Blood–brain barrier P-glycoprotein function in Alzheimer's disease

Daniëlle M. E. van Assema, Mark Lubberink, Martin Bauer et al. · Brain · 2011 · 315 citations · Full text

, , +17

P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study

M Feldmann, Marie-Claude Asselin, Joan Liu et al. · The Lancet Neurology · 2013 · 181 citations · Full text

, , +5

Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate<i>R</i>‐[<sup>11</sup>C]verapamil

Oliver Langer, Martin Bauer, Alexander Hammers et al. · Epilepsia · 2007 · 139 citations · Full text

, , +17

Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data

Martin Bauer, Markus Zeitlinger, Rudolf Karch et al. · Clinical Pharmacology & Therapeutics · 2011 · 119 citations

, , +17

Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET

Claudia Kuntner, Jens P. Bankstahl, Marion Bankstahl et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 118 citations · Full text

, , +15

1–5 of 120